Coagulation Factor Viia Recombinant Human: Side Effects, Uses & Monitoring
SEVENFACT is indicated for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors.
- Data source
- FDA labeling via NIH DailyMed (label b23ad666…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
SEVENFACT is indicated for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors. Limitation s of Use: SEVENFACT is not indicated for the treatment of patients with congenital Factor VII deficiency.
Conditions associated with Coagulation Factor Viia Recombinant Human in labeling
Congenital factor VII deficiency
Congenital factor VII deficiency is a medical condition that may be associated with various symptoms and signs...
Factor VII deficiency
Factor VII deficiency is a medical condition that may be associated with various symptoms and signs....
Hemophilia A
Hemophilia A is a medical condition that may be associated with various symptoms and signs....
Frequently Asked Questions
What is Coagulation Factor Viia Recombinant Human used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Coagulation Factor Viia Recombinant Human?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Coagulation Factor Viia Recombinant Human require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Coagulation Factor Viia Recombinant Human.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.